Biolase, Inc.

BIOL

Market cap $4.31M

Delisted

BIOL was delisted on the 18th of June, 2024.

#	Name	Holding	Trade Value	Shares Change	Change in Stake
1	OIM 1 Oracle Investment Management Greenwich, Connecticut	$12.3M	–	–	–
2	CCM 2 Camber Capital Management Boston, Massachusetts	$6.24M	–	–	–
3	3 Vanguard Group Malvern, Pennsylvania	$1.87M	–	–	–
4	BIT 4 BlackRock Institutional Trust San Francisco, California	$1.61M	–	–	–
5	BC 5 Birchview Capital Burlington, Vermont	$1.5M	–	–	–
6	CCM 6 Consonance Capital Management New York	$1.47M	+$15.8K	+1	+1%
7	TA 7 Teton Advisors Rye, New York	$400K	–	–	–
8	PCMI 8 Princeton Capital Management Inc Princeton, New Jersey	$352K	–	–	–
9	9 Geode Capital Management Boston, Massachusetts	$228K	–	–	–
10	10 D.E. Shaw & Co New York	$205K	–	–	–
11	11 California Public Employees Retirement System Sacramento, California	$145K	–	–	–
12	BFA 12 BlackRock Fund Advisors San Francisco, California	$118K	–	–	–
13	13 Morgan Stanley New York	$108K	-$15.8K	-1	-13%
14	GI 14 GAMCO Investors Greenwich, Connecticut	$107K	–	–	–
15	15 Northern Trust Chicago, Illinois	$104K	+$15.8K	+1	+17%
16	16 Deutsche Bank Frankfurt Am Main Ge, Germany	$84K	–	–	–
17	TMC 17 Trellus Management Company Delray Beach, Florida	$71K	–	–	–
18	18 Citadel Advisors Miami, Florida	$69K	+$47.5K	+3	+150%
19	GF 19 Gabelli Funds Rye, New York	$50K	–	–	–
20	20 Bank of New York Mellon New York	$49K	–	–	–
21	21 Goldman Sachs New York	$43K	–	–	–
22	SBIA 22 Sheaff Brock Investment Advisors Indianapolis, Indiana	$33K	–	–	–
23	BIP 23 Brandes Investment Partners La Jolla, California	$27K	+$31.6K	+2	New
24	24 Stifel Financial St. Louis, Missouri	$23K	–	–	–
25	25 State Street Boston, Massachusetts	$22K	–	–	–

Biolase, Inc. BIOL Market cap $4.31M

Biolase, Inc.

BIOL

Market cap $4.31M